Global Tumor-on-a-chip Supply, Demand and Key Producers, 2023-2029
The global Tumor-on-a-chip market size is expected to reach $ 54 million by 2029, rising at a market growth of 30.8% CAGR during the forecast period (2023-2029).
This report studies the global Tumor-on-a-chip demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor-on-a-chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor-on-a-chip that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor-on-a-chip total market, 2018-2029, (USD Million)
Global Tumor-on-a-chip total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor-on-a-chip total market, key domestic companies and share, (USD Million)
Global Tumor-on-a-chip revenue by player and market share 2018-2023, (USD Million)
Global Tumor-on-a-chip total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor-on-a-chip total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Tumor-on-a-chip market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellesce, Daxiang Biotech, Mimetas, InSphero, Hepregen and Charles River, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor-on-a-chip market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor-on-a-chip Market, By Region:
1. How big is the global Tumor-on-a-chip market?
2. What is the demand of the global Tumor-on-a-chip market?
3. What is the year over year growth of the global Tumor-on-a-chip market?
4. What is the total value of the global Tumor-on-a-chip market?
5. Who are the major players in the global Tumor-on-a-chip market?
6. What are the growth factors driving the market demand?
This report studies the global Tumor-on-a-chip demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor-on-a-chip, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor-on-a-chip that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor-on-a-chip total market, 2018-2029, (USD Million)
Global Tumor-on-a-chip total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Tumor-on-a-chip total market, key domestic companies and share, (USD Million)
Global Tumor-on-a-chip revenue by player and market share 2018-2023, (USD Million)
Global Tumor-on-a-chip total market by Type, CAGR, 2018-2029, (USD Million)
Global Tumor-on-a-chip total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Tumor-on-a-chip market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellesce, Daxiang Biotech, Mimetas, InSphero, Hepregen and Charles River, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor-on-a-chip market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Tumor-on-a-chip Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- PDX Model
- CDX Model
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Cellesce
- Daxiang Biotech
- Mimetas
- InSphero
- Hepregen
- Charles River
1. How big is the global Tumor-on-a-chip market?
2. What is the demand of the global Tumor-on-a-chip market?
3. What is the year over year growth of the global Tumor-on-a-chip market?
4. What is the total value of the global Tumor-on-a-chip market?
5. Who are the major players in the global Tumor-on-a-chip market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tumor-on-a-chip Introduction
1.2 World Tumor-on-a-chip Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor-on-a-chip Total Market by Region (by Headquarter Location)
1.3.1 World Tumor-on-a-chip Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor-on-a-chip Market Size (2018-2029)
1.3.3 China Tumor-on-a-chip Market Size (2018-2029)
1.3.4 Europe Tumor-on-a-chip Market Size (2018-2029)
1.3.5 Japan Tumor-on-a-chip Market Size (2018-2029)
1.3.6 South Korea Tumor-on-a-chip Market Size (2018-2029)
1.3.7 ASEAN Tumor-on-a-chip Market Size (2018-2029)
1.3.8 India Tumor-on-a-chip Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor-on-a-chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor-on-a-chip Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor-on-a-chip Consumption Value (2018-2029)
2.2 World Tumor-on-a-chip Consumption Value by Region
2.2.1 World Tumor-on-a-chip Consumption Value by Region (2018-2023)
2.2.2 World Tumor-on-a-chip Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor-on-a-chip Consumption Value (2018-2029)
2.4 China Tumor-on-a-chip Consumption Value (2018-2029)
2.5 Europe Tumor-on-a-chip Consumption Value (2018-2029)
2.6 Japan Tumor-on-a-chip Consumption Value (2018-2029)
2.7 South Korea Tumor-on-a-chip Consumption Value (2018-2029)
2.8 ASEAN Tumor-on-a-chip Consumption Value (2018-2029)
2.9 India Tumor-on-a-chip Consumption Value (2018-2029)
3 WORLD TUMOR-ON-A-CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor-on-a-chip Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor-on-a-chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor-on-a-chip in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor-on-a-chip in 2022
3.3 Tumor-on-a-chip Company Evaluation Quadrant
3.4 Tumor-on-a-chip Market: Overall Company Footprint Analysis
3.4.1 Tumor-on-a-chip Market: Region Footprint
3.4.2 Tumor-on-a-chip Market: Company Product Type Footprint
3.4.3 Tumor-on-a-chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor-on-a-chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor-on-a-chip Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor-on-a-chip Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor-on-a-chip Consumption Value Comparison
4.2.1 United States VS China: Tumor-on-a-chip Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor-on-a-chip Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor-on-a-chip Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor-on-a-chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor-on-a-chip Revenue, (2018-2023)
4.4 China Based Companies Tumor-on-a-chip Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor-on-a-chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor-on-a-chip Revenue, (2018-2023)
4.5 Rest of World Based Tumor-on-a-chip Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor-on-a-chip Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor-on-a-chip Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor-on-a-chip Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PDX Model
5.2.2 CDX Model
5.3 Market Segment by Type
5.3.1 World Tumor-on-a-chip Market Size by Type (2018-2023)
5.3.2 World Tumor-on-a-chip Market Size by Type (2024-2029)
5.3.3 World Tumor-on-a-chip Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor-on-a-chip Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Academic & Research Institutes
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Tumor-on-a-chip Market Size by Application (2018-2023)
6.3.2 World Tumor-on-a-chip Market Size by Application (2024-2029)
6.3.3 World Tumor-on-a-chip Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cellesce
7.1.1 Cellesce Details
7.1.2 Cellesce Major Business
7.1.3 Cellesce Tumor-on-a-chip Product and Services
7.1.4 Cellesce Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cellesce Recent Developments/Updates
7.1.6 Cellesce Competitive Strengths & Weaknesses
7.2 Daxiang Biotech
7.2.1 Daxiang Biotech Details
7.2.2 Daxiang Biotech Major Business
7.2.3 Daxiang Biotech Tumor-on-a-chip Product and Services
7.2.4 Daxiang Biotech Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Daxiang Biotech Recent Developments/Updates
7.2.6 Daxiang Biotech Competitive Strengths & Weaknesses
7.3 Mimetas
7.3.1 Mimetas Details
7.3.2 Mimetas Major Business
7.3.3 Mimetas Tumor-on-a-chip Product and Services
7.3.4 Mimetas Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Mimetas Recent Developments/Updates
7.3.6 Mimetas Competitive Strengths & Weaknesses
7.4 InSphero
7.4.1 InSphero Details
7.4.2 InSphero Major Business
7.4.3 InSphero Tumor-on-a-chip Product and Services
7.4.4 InSphero Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 InSphero Recent Developments/Updates
7.4.6 InSphero Competitive Strengths & Weaknesses
7.5 Hepregen
7.5.1 Hepregen Details
7.5.2 Hepregen Major Business
7.5.3 Hepregen Tumor-on-a-chip Product and Services
7.5.4 Hepregen Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hepregen Recent Developments/Updates
7.5.6 Hepregen Competitive Strengths & Weaknesses
7.6 Charles River
7.6.1 Charles River Details
7.6.2 Charles River Major Business
7.6.3 Charles River Tumor-on-a-chip Product and Services
7.6.4 Charles River Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Charles River Recent Developments/Updates
7.6.6 Charles River Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor-on-a-chip Industry Chain
8.2 Tumor-on-a-chip Upstream Analysis
8.3 Tumor-on-a-chip Midstream Analysis
8.4 Tumor-on-a-chip Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Tumor-on-a-chip Introduction
1.2 World Tumor-on-a-chip Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Tumor-on-a-chip Total Market by Region (by Headquarter Location)
1.3.1 World Tumor-on-a-chip Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Tumor-on-a-chip Market Size (2018-2029)
1.3.3 China Tumor-on-a-chip Market Size (2018-2029)
1.3.4 Europe Tumor-on-a-chip Market Size (2018-2029)
1.3.5 Japan Tumor-on-a-chip Market Size (2018-2029)
1.3.6 South Korea Tumor-on-a-chip Market Size (2018-2029)
1.3.7 ASEAN Tumor-on-a-chip Market Size (2018-2029)
1.3.8 India Tumor-on-a-chip Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor-on-a-chip Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor-on-a-chip Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Tumor-on-a-chip Consumption Value (2018-2029)
2.2 World Tumor-on-a-chip Consumption Value by Region
2.2.1 World Tumor-on-a-chip Consumption Value by Region (2018-2023)
2.2.2 World Tumor-on-a-chip Consumption Value Forecast by Region (2024-2029)
2.3 United States Tumor-on-a-chip Consumption Value (2018-2029)
2.4 China Tumor-on-a-chip Consumption Value (2018-2029)
2.5 Europe Tumor-on-a-chip Consumption Value (2018-2029)
2.6 Japan Tumor-on-a-chip Consumption Value (2018-2029)
2.7 South Korea Tumor-on-a-chip Consumption Value (2018-2029)
2.8 ASEAN Tumor-on-a-chip Consumption Value (2018-2029)
2.9 India Tumor-on-a-chip Consumption Value (2018-2029)
3 WORLD TUMOR-ON-A-CHIP COMPANIES COMPETITIVE ANALYSIS
3.1 World Tumor-on-a-chip Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor-on-a-chip Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor-on-a-chip in 2022
3.2.3 Global Concentration Ratios (CR8) for Tumor-on-a-chip in 2022
3.3 Tumor-on-a-chip Company Evaluation Quadrant
3.4 Tumor-on-a-chip Market: Overall Company Footprint Analysis
3.4.1 Tumor-on-a-chip Market: Region Footprint
3.4.2 Tumor-on-a-chip Market: Company Product Type Footprint
3.4.3 Tumor-on-a-chip Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tumor-on-a-chip Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor-on-a-chip Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Tumor-on-a-chip Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Tumor-on-a-chip Consumption Value Comparison
4.2.1 United States VS China: Tumor-on-a-chip Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Tumor-on-a-chip Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Tumor-on-a-chip Companies and Market Share, 2018-2023
4.3.1 United States Based Tumor-on-a-chip Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor-on-a-chip Revenue, (2018-2023)
4.4 China Based Companies Tumor-on-a-chip Revenue and Market Share, 2018-2023
4.4.1 China Based Tumor-on-a-chip Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor-on-a-chip Revenue, (2018-2023)
4.5 Rest of World Based Tumor-on-a-chip Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Tumor-on-a-chip Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor-on-a-chip Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Tumor-on-a-chip Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 PDX Model
5.2.2 CDX Model
5.3 Market Segment by Type
5.3.1 World Tumor-on-a-chip Market Size by Type (2018-2023)
5.3.2 World Tumor-on-a-chip Market Size by Type (2024-2029)
5.3.3 World Tumor-on-a-chip Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Tumor-on-a-chip Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical & Biotechnology Companies
6.2.2 Academic & Research Institutes
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Tumor-on-a-chip Market Size by Application (2018-2023)
6.3.2 World Tumor-on-a-chip Market Size by Application (2024-2029)
6.3.3 World Tumor-on-a-chip Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cellesce
7.1.1 Cellesce Details
7.1.2 Cellesce Major Business
7.1.3 Cellesce Tumor-on-a-chip Product and Services
7.1.4 Cellesce Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cellesce Recent Developments/Updates
7.1.6 Cellesce Competitive Strengths & Weaknesses
7.2 Daxiang Biotech
7.2.1 Daxiang Biotech Details
7.2.2 Daxiang Biotech Major Business
7.2.3 Daxiang Biotech Tumor-on-a-chip Product and Services
7.2.4 Daxiang Biotech Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Daxiang Biotech Recent Developments/Updates
7.2.6 Daxiang Biotech Competitive Strengths & Weaknesses
7.3 Mimetas
7.3.1 Mimetas Details
7.3.2 Mimetas Major Business
7.3.3 Mimetas Tumor-on-a-chip Product and Services
7.3.4 Mimetas Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Mimetas Recent Developments/Updates
7.3.6 Mimetas Competitive Strengths & Weaknesses
7.4 InSphero
7.4.1 InSphero Details
7.4.2 InSphero Major Business
7.4.3 InSphero Tumor-on-a-chip Product and Services
7.4.4 InSphero Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 InSphero Recent Developments/Updates
7.4.6 InSphero Competitive Strengths & Weaknesses
7.5 Hepregen
7.5.1 Hepregen Details
7.5.2 Hepregen Major Business
7.5.3 Hepregen Tumor-on-a-chip Product and Services
7.5.4 Hepregen Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Hepregen Recent Developments/Updates
7.5.6 Hepregen Competitive Strengths & Weaknesses
7.6 Charles River
7.6.1 Charles River Details
7.6.2 Charles River Major Business
7.6.3 Charles River Tumor-on-a-chip Product and Services
7.6.4 Charles River Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Charles River Recent Developments/Updates
7.6.6 Charles River Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Tumor-on-a-chip Industry Chain
8.2 Tumor-on-a-chip Upstream Analysis
8.3 Tumor-on-a-chip Midstream Analysis
8.4 Tumor-on-a-chip Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Tumor-on-a-chip Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor-on-a-chip Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor-on-a-chip Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor-on-a-chip Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor-on-a-chip Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor-on-a-chip Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor-on-a-chip Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor-on-a-chip Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor-on-a-chip Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor-on-a-chip Players in 2022
Table 12. World Tumor-on-a-chip Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor-on-a-chip Company Evaluation Quadrant
Table 14. Head Office of Key Tumor-on-a-chip Player
Table 15. Tumor-on-a-chip Market: Company Product Type Footprint
Table 16. Tumor-on-a-chip Market: Company Product Application Footprint
Table 17. Tumor-on-a-chip Mergers & Acquisitions Activity
Table 18. United States VS China Tumor-on-a-chip Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor-on-a-chip Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor-on-a-chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 23. China Based Tumor-on-a-chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor-on-a-chip Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 29. World Tumor-on-a-chip Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor-on-a-chip Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor-on-a-chip Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor-on-a-chip Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor-on-a-chip Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor-on-a-chip Market Size by Application (2024-2029) & (USD Million)
Table 35. Cellesce Basic Information, Area Served and Competitors
Table 36. Cellesce Major Business
Table 37. Cellesce Tumor-on-a-chip Product and Services
Table 38. Cellesce Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cellesce Recent Developments/Updates
Table 40. Cellesce Competitive Strengths & Weaknesses
Table 41. Daxiang Biotech Basic Information, Area Served and Competitors
Table 42. Daxiang Biotech Major Business
Table 43. Daxiang Biotech Tumor-on-a-chip Product and Services
Table 44. Daxiang Biotech Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Daxiang Biotech Recent Developments/Updates
Table 46. Daxiang Biotech Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Area Served and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Tumor-on-a-chip Product and Services
Table 50. Mimetas Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. InSphero Basic Information, Area Served and Competitors
Table 54. InSphero Major Business
Table 55. InSphero Tumor-on-a-chip Product and Services
Table 56. InSphero Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. InSphero Recent Developments/Updates
Table 58. InSphero Competitive Strengths & Weaknesses
Table 59. Hepregen Basic Information, Area Served and Competitors
Table 60. Hepregen Major Business
Table 61. Hepregen Tumor-on-a-chip Product and Services
Table 62. Hepregen Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hepregen Recent Developments/Updates
Table 64. Charles River Basic Information, Area Served and Competitors
Table 65. Charles River Major Business
Table 66. Charles River Tumor-on-a-chip Product and Services
Table 67. Charles River Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Tumor-on-a-chip Upstream (Raw Materials)
Table 69. Tumor-on-a-chip Typical Customers
Table 1. World Tumor-on-a-chip Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Tumor-on-a-chip Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Tumor-on-a-chip Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Tumor-on-a-chip Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Tumor-on-a-chip Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tumor-on-a-chip Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Tumor-on-a-chip Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Tumor-on-a-chip Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Tumor-on-a-chip Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Tumor-on-a-chip Players in 2022
Table 12. World Tumor-on-a-chip Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Tumor-on-a-chip Company Evaluation Quadrant
Table 14. Head Office of Key Tumor-on-a-chip Player
Table 15. Tumor-on-a-chip Market: Company Product Type Footprint
Table 16. Tumor-on-a-chip Market: Company Product Application Footprint
Table 17. Tumor-on-a-chip Mergers & Acquisitions Activity
Table 18. United States VS China Tumor-on-a-chip Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Tumor-on-a-chip Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Tumor-on-a-chip Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 23. China Based Tumor-on-a-chip Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 26. Rest of World Based Tumor-on-a-chip Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Tumor-on-a-chip Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Tumor-on-a-chip Revenue Market Share (2018-2023)
Table 29. World Tumor-on-a-chip Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Tumor-on-a-chip Market Size by Type (2018-2023) & (USD Million)
Table 31. World Tumor-on-a-chip Market Size by Type (2024-2029) & (USD Million)
Table 32. World Tumor-on-a-chip Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Tumor-on-a-chip Market Size by Application (2018-2023) & (USD Million)
Table 34. World Tumor-on-a-chip Market Size by Application (2024-2029) & (USD Million)
Table 35. Cellesce Basic Information, Area Served and Competitors
Table 36. Cellesce Major Business
Table 37. Cellesce Tumor-on-a-chip Product and Services
Table 38. Cellesce Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cellesce Recent Developments/Updates
Table 40. Cellesce Competitive Strengths & Weaknesses
Table 41. Daxiang Biotech Basic Information, Area Served and Competitors
Table 42. Daxiang Biotech Major Business
Table 43. Daxiang Biotech Tumor-on-a-chip Product and Services
Table 44. Daxiang Biotech Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Daxiang Biotech Recent Developments/Updates
Table 46. Daxiang Biotech Competitive Strengths & Weaknesses
Table 47. Mimetas Basic Information, Area Served and Competitors
Table 48. Mimetas Major Business
Table 49. Mimetas Tumor-on-a-chip Product and Services
Table 50. Mimetas Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Mimetas Recent Developments/Updates
Table 52. Mimetas Competitive Strengths & Weaknesses
Table 53. InSphero Basic Information, Area Served and Competitors
Table 54. InSphero Major Business
Table 55. InSphero Tumor-on-a-chip Product and Services
Table 56. InSphero Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. InSphero Recent Developments/Updates
Table 58. InSphero Competitive Strengths & Weaknesses
Table 59. Hepregen Basic Information, Area Served and Competitors
Table 60. Hepregen Major Business
Table 61. Hepregen Tumor-on-a-chip Product and Services
Table 62. Hepregen Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hepregen Recent Developments/Updates
Table 64. Charles River Basic Information, Area Served and Competitors
Table 65. Charles River Major Business
Table 66. Charles River Tumor-on-a-chip Product and Services
Table 67. Charles River Tumor-on-a-chip Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Tumor-on-a-chip Upstream (Raw Materials)
Table 69. Tumor-on-a-chip Typical Customers
LIST OF FIGURES
Figure 1. Tumor-on-a-chip Picture
Figure 2. World Tumor-on-a-chip Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor-on-a-chip Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor-on-a-chip Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor-on-a-chip Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 13. Tumor-on-a-chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor-on-a-chip Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor-on-a-chip by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor-on-a-chip Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor-on-a-chip Markets in 2022
Figure 27. United States VS China: Tumor-on-a-chip Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor-on-a-chip Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor-on-a-chip Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor-on-a-chip Market Size Market Share by Type in 2022
Figure 31. PDX Model
Figure 32. CDX Model
Figure 33. World Tumor-on-a-chip Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor-on-a-chip Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor-on-a-chip Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical & Biotechnology Companies
Figure 37. Academic & Research Institutes
Figure 38. Others
Figure 39. Tumor-on-a-chip Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Tumor-on-a-chip Picture
Figure 2. World Tumor-on-a-chip Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Tumor-on-a-chip Total Market Size (2018-2029) & (USD Million)
Figure 4. World Tumor-on-a-chip Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Tumor-on-a-chip Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Tumor-on-a-chip Revenue (2018-2029) & (USD Million)
Figure 13. Tumor-on-a-chip Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 16. World Tumor-on-a-chip Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 18. China Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 23. India Tumor-on-a-chip Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Tumor-on-a-chip by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tumor-on-a-chip Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tumor-on-a-chip Markets in 2022
Figure 27. United States VS China: Tumor-on-a-chip Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Tumor-on-a-chip Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Tumor-on-a-chip Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Tumor-on-a-chip Market Size Market Share by Type in 2022
Figure 31. PDX Model
Figure 32. CDX Model
Figure 33. World Tumor-on-a-chip Market Size Market Share by Type (2018-2029)
Figure 34. World Tumor-on-a-chip Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Tumor-on-a-chip Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical & Biotechnology Companies
Figure 37. Academic & Research Institutes
Figure 38. Others
Figure 39. Tumor-on-a-chip Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
